Avidity Biosciences Inc (RNA)
43.22
-0.43
(-0.99%)
USD |
NASDAQ |
Nov 21, 14:18
Avidity Biosciences Price: 43.22 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 42.82 | 44.64 | 42.20 | 43.65 | 675384.0 |
| Nov 19, 2024 | 40.45 | 43.38 | 40.39 | 43.25 | 1.114M |
| Nov 18, 2024 | 42.02 | 42.32 | 39.50 | 41.35 | 1.148M |
| Nov 15, 2024 | 50.32 | 50.32 | 41.84 | 42.18 | 2.000M |
| Nov 14, 2024 | 53.55 | 54.24 | 49.81 | 49.97 | 1.763M |
| Nov 13, 2024 | 47.32 | 56.00 | 46.82 | 52.50 | 3.218M |
| Nov 12, 2024 | 46.06 | 47.99 | 45.65 | 46.73 | 1.082M |
| Nov 11, 2024 | 47.09 | 48.32 | 46.44 | 47.12 | 979322.0 |
| Nov 08, 2024 | 46.76 | 47.30 | 44.85 | 46.72 | 1.076M |
| Nov 07, 2024 | 47.38 | 48.72 | 46.47 | 47.51 | 845477.0 |
| Nov 06, 2024 | 46.85 | 47.30 | 44.30 | 47.24 | 1.272M |
| Nov 05, 2024 | 44.82 | 45.43 | 43.39 | 45.09 | 764852.0 |
| Nov 04, 2024 | 41.40 | 45.58 | 41.12 | 44.82 | 1.451M |
| Nov 01, 2024 | 42.74 | 43.48 | 41.36 | 41.87 | 1.122M |
| Oct 31, 2024 | 43.10 | 43.17 | 42.18 | 42.26 | 854008.0 |
| Oct 30, 2024 | 44.05 | 44.61 | 43.22 | 43.22 | 549653.0 |
| Oct 29, 2024 | 45.24 | 45.67 | 44.03 | 44.57 | 485921.0 |
| Oct 28, 2024 | 46.01 | 46.64 | 45.40 | 45.72 | 629603.0 |
| Oct 25, 2024 | 45.50 | 46.30 | 45.08 | 45.11 | 575049.0 |
| Oct 24, 2024 | 45.47 | 46.29 | 44.75 | 45.15 | 417530.0 |
| Oct 23, 2024 | 47.13 | 47.29 | 45.24 | 45.40 | 793584.0 |
| Oct 22, 2024 | 46.15 | 48.23 | 46.15 | 47.38 | 489205.0 |
| Oct 21, 2024 | 49.96 | 50.40 | 45.83 | 46.71 | 1.168M |
| Oct 18, 2024 | 48.50 | 50.78 | 47.80 | 50.45 | 1.212M |
| Oct 17, 2024 | 48.74 | 49.12 | 48.02 | 48.52 | 634881.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.87
Minimum
Oct 27 2023
52.50
Maximum
Nov 13 2024
21.88
Average
21.90
Median
Price Benchmarks
| Sarepta Therapeutics Inc | 110.39 |
| Vertex Pharmaceuticals Inc | 450.16 |
| Natera Inc | 169.38 |
| Entrada Therapeutics Inc | 18.19 |
| Alnylam Pharmaceuticals Inc | 247.94 |
Price Related Metrics
| PS Ratio | 420.37 |
| Price to Book Value | 3.430 |
| Earnings Yield | -6.69% |
| Market Cap | 5.157B |